California AB641 establishes a Drug-Induced Movement Disorder Awareness Program to educate about medication-related movement disorders.
California AB641 mandates the State Department of Public Health to create a program to raise awareness about drug-induced movement disorders, focusing on education and outreach. The program includes providing evidence-based educational information on screening and identifying symptoms, and developing guidance on clinical standards for treating these disorders, including via telehealth. The bill also aims to eliminate stigma for people living with these disorders related to mental health treatment. The program will remain in effect until January 1, 2031, after which it is repealed.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.